Rapid manufacturing of a universal flu vaccine using TMV-conjugated centralized antigens

Active Project Grant Awarded Last action

Award ID
R01AI147109
Recipient
Awarding agency
Obligated
$5,158,869

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date 91% complete
Originally
Funding
  • $4,525,227.00 Federal
  • $633,642.00 Non-federal
Place of performance
Lincoln, NE 68503, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $653,985 $0
Amendment $661,752 $0
Amendment $661,752 $0
Amendment $619,095 $0
Amendment $633,642 $0
Amendment $633,642 $633,642
Amendment $0 $0
Original award $661,359 $0

Subawards

Subrecipient Amount Awarded
University Of California, Davis Rapid Manufacturing of a Universal Flu Vaccine Using TMV-conjugated Centralized Antigens $220,115
ST Jude Children's Research Hospital Inc. $109,145
Touro University $628,442

Quick answers

Who received award R01AI147109?

R01AI147109 was awarded to Board Of Regents Of The University Of Nebraska by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 1, 2020.

How much is award R01AI147109 worth?

$5,158,869 has been obligated on R01AI147109: $4,525,227 in federal funding and $633,642 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award